These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 776650)

  • 21. Evaluation of susceptibility of Mycobacterium bovis to antituberculous drugs by radiometric BACTEC 460TB system.
    Cavirani S; Fanti F; Benecchi M; Calderaro A; Taddei S; Arcangeletti C; Medici MC; Dettori G; Chezzi C
    New Microbiol; 2003 Apr; 26(2):181-6. PubMed ID: 12737201
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The resistance rates of Mycobacterium tuberculosis strains to antituberculosis drugs: evaluation of two years' data in Aegean region, Turkey].
    Güneri S; Unsal I; Oztop A; Erkut M; Avkan Oğuz V; Ozgü A; Cakmak R
    Mikrobiyol Bul; 2004 Jul; 38(3):203-12. PubMed ID: 15490839
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Influence of antitubercular agents on the endogenous metabolism of mycobacteria].
    Iwainsky H; Reutgen H
    Z Tuberk Erkr Thoraxorg; 1968; 128(1):227-31. PubMed ID: 4973007
    [No Abstract]   [Full Text] [Related]  

  • 24. Drug resistance to the first line of antitubercular regimen (a preliminary report).
    Varaiya A; Gogate A
    Indian J Public Health; 1998; 42(4):126-30. PubMed ID: 10389525
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rapid mycobacteria drug susceptibility testing using Gel Microdrop (GMD) Growth Assay and flow cytometry.
    Akselband Y; Cabral C; Shapiro DS; McGrath P
    J Microbiol Methods; 2005 Aug; 62(2):181-97. PubMed ID: 16009276
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug resistance of Mycobacterium tuberculosis strains isolated from patients with pulmonary tuberculosis in Archangels, Russia.
    Toungoussova S; Caugant DA; Sandven P; Mariandyshev AO; Bjune G
    Int J Tuberc Lung Dis; 2002 May; 6(5):406-14. PubMed ID: 12019916
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The susceptibility of mycobacteria to rifamide and rifampicin.
    Clark J; Wallace A
    Tubercle; 1967 Jun; 48(2):144-8. PubMed ID: 4293697
    [No Abstract]   [Full Text] [Related]  

  • 28. [Comparative data from an experimental-clinical study of new antituberculosis drugs].
    Utkin VV
    Antibiotiki; 1972 Sep; 17(9):851-6. PubMed ID: 4631726
    [No Abstract]   [Full Text] [Related]  

  • 29. [Activity of the second-line preparations, ethambutol and rifampin, in experimental tuberculosis caused by Mycobacterium tuberculosis highly resistant to basic tuberculostatics].
    Golyshevskaia VI; El'shanskaia MP
    Probl Tuberk; 1973; 51(12):60-4. PubMed ID: 4205666
    [No Abstract]   [Full Text] [Related]  

  • 30. [Sensitivity tests of mycobacteria to INH, SM, EMB and RMP in a semi-liquid serum-sauton-agar (author's transl)].
    Neubert R
    Z Erkr Atmungsorgane; 1976; 144(1):63-8. PubMed ID: 823718
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Study of drug resistance in previously treated tuberculosis patients in Gujarat, India.
    Shah AR; Agarwal SK; Shah KV
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1098-101. PubMed ID: 12546118
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of initial drug resistance to M. tuberculosis in new sputum positive RNTCP patients.
    Dhingra VK; Rajpal S; Bhalla P; Yadav A; Jain SK; Hanif M
    J Commun Dis; 2003 Jun; 35(2):82-9. PubMed ID: 15562953
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Components of monitoring drug resistance of tuberculosis agent in the evaluation of effectiveness of the national tuberculosis control program].
    Popov SA; Dorozhkova IR; Medvedeva IM
    Probl Tuberk; 2001; (2):18-20. PubMed ID: 11490457
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antimycobacterial and synergistic effects of 18β-glycyrrhetinic acid or glycyrrhetinic acid-30-piperazine in combination with isoniazid, rifampicin or streptomycin against Mycobacterium bovis.
    Zhou X; Zhao L; Liu X; Li X; Jia F; Zhang Y; Wang Y
    Phytother Res; 2012 Feb; 26(2):253-8. PubMed ID: 21656601
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary resistance to anti-tuberculosis drugs in Addis Ababa, Ethiopia.
    Demissie M; Gebeyehu M; Berhane Y
    Int J Tuberc Lung Dis; 1997 Feb; 1(1):64-7. PubMed ID: 9441061
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro activity of C-8-methoxy fluoroquinolones against mycobacteria when combined with anti-tuberculosis agents.
    Lu T; Drlica K
    J Antimicrob Chemother; 2003 Dec; 52(6):1025-8. PubMed ID: 14613961
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rapid speciation of 15 clinically relevant mycobacteria with simultaneous detection of resistance to rifampin, isoniazid, and streptomycin in Mycobacterium tuberculosis complex.
    Shenai S; Rodrigues C; Mehta A
    Int J Infect Dis; 2009 Jan; 13(1):46-58. PubMed ID: 18565777
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary and acquired drug resistance in Mycobacterium tuberculosis strains in western region of Libyan Arab Jamahiriya.
    Elghoul MT; Joshi RM; Rizghalla T
    Trop Geogr Med; 1989 Oct; 41(4):304-8. PubMed ID: 2517554
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stability of Ethambutol [d-2,2'-(ethylenediimino)-di-I-butanol] resistant mycobacteria grown in the absence of Ethambutol.
    Gupta SK; Mathur IS
    Indian J Exp Biol; 1965 Jul; 3(3):176-7. PubMed ID: 5320364
    [No Abstract]   [Full Text] [Related]  

  • 40. In vitro drug susceptibility of 2275 clinical non-tuberculous Mycobacterium isolates of 49 species in The Netherlands.
    van Ingen J; van der Laan T; Dekhuijzen R; Boeree M; van Soolingen D
    Int J Antimicrob Agents; 2010 Feb; 35(2):169-73. PubMed ID: 20006470
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.